Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid Servicesnor-MC3 is an ionizable cationic lipid that has been used in the generation of liposomal lipid nanoparticles (LNPs) for the delivery of mRNA in vitro and in vivo and is a derivative of DLin-MC3-DMA (Item No. 34364).1 Liposomal LNPs containing nor-MC3 at a molar ratio of 20:40:40:1.5 for nor-MC3:egg sphingomyelin:cholesterol:DMG-PEG(2000) compared with those with a molar ratio of 50:10:38.5:1.5 exhibit higher transfection efficiencies in vitro. Liposomal LNPs containing nor-MC3 at a molar ratio of 20:40:40:1.5 accumulate in the spleen, pancreas, heart, kidney, muscle, and inguinal lymph nodes in mice to a greater extent than those with a molar ratio of 50:10:38.5:1.5.
WARNING This product is not for human or veterinary use.
1. Liposomal lipid nanoparticles for extrahepatic delivery of mRNA. Nat. Commun. 16(1), (2025).